TransMedics Group
TMDX
NASDAQ
IPO2019
about TMDX
TransMedics Group specializes in developing advanced medical technologies for organ transplant preservation and surgical support systems.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $133.10 | $133.55 | $131.01 | $4.45B | 649.06K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.03 | 64.11 | 34.53 | 23.24% | 22.18% | 0% |